Evidence map

ArticleDiabetologia2026

Dapagliflozin does not impair LDL catabolism and induces a shift towards a closer to normal VLDL

Bruno Vergès et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 42467086